Full Text (PDF)
Original Article

Pathophysiological Changes in Nerve Conduction Studies in Diabetic Peripheral Neuropathy: An Integrative Overview

Kumar Senthil P. , Kumar Senthil P. , Adhikari Prabha , Jeganathan P.S. , D’Souza Sydney C. , Misri Z.K.

Author Information

Licence:




Indian Journal of Pathology: Research and Practice 2(3):p 85-98, Sept - Dec 2013. | DOI:

How Cite This Article:


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Background: Nerve conduction studies (NCSs) involve the delivery of electric stimuli to peripheral nerves at accessible locations on the human body and the recording of electrophysiological responses. NCSs are considered as important evaluation tools for peripheral neuropathy (PN) and common disabling cause for PN is diabetic peripheral neuropathy (DPN). Objective: To perform an integrative overview on evidence for nerve conduction and its pathophysiological changes due to DPN in terms of assessment and treatment studies. Methods: A systematic review was performed using search terms ‘diabetic neuropathy’ and ‘nerve conduction’ in PubMed, CINAHL and Google scholar to identify relevant studies based upon their title, abstract and fulltext and they were descriptively synthesized for their data and reported for measurement properties, comparison with other assessments and studying efficacy of interventions. Results: Of the total 45 included studies, 17 studies were on measurement properties (sensitivity/specificity=2, reliability=3, population comparison=3, prevalence=7, anthropometric factors=2); 12 studies compared NCSs with other assessment methods (clinical examination=2, clinical scales=4, current perception thresholds=1, electromyography=1, exercise-induced stress=1, ultrasonography=1, vibration perception thresholds=1, nerve morphology=1); and, 16 studies used NCSs as a therapeutic outcome measure for effects of interventions (4-methylcatechol=1, acetyl-l carnitine=1, adenosine=1, carbamazepine=1, pancreatic transplantation=1, alpha lipoic acid=2, fidarestat=2, gangliosides=1, insulin therapy=1, vitamins=1, ponalrestat=1, silymarin=1, sorbinil=1, zenarestat=1).Conclusion: NCSs remain to be established as a ‘stand-alone’ gold-standard objective and accurate assessment tool for diagnosis, therapeutic and prognostic decision-making for patients with DPN. 
 
Keywords: Neurophysiology; Diabetic polyneuropathy; Electrodiagnosis; Electrophysiology; Physical examination.   


References

No records found.


About this article


Cite this article


Licence:




Received Accepted Published
N/A N/A N/A

DOI:

Keywords


Article Level Metrics

Last Updated

Sunday 12 July 2026, 13:45:31 (IST)


2018

Accesses

4
434
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share